Biffa - BIFF Share Forecast, Price & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Biffa in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" BIFF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BIFF, but not buy additional shares or sell existing shares.
View BIFF analyst ratings or view top-rated stocks.

3 equities research analysts have issued 12-month price objectives for Biffa's stock. Their BIFF share price forecasts range from GBX 395 to GBX 465. On average, they predict the company's share price to reach GBX 418.33 in the next twelve months. This suggests a possible upside of 4.0% from the stock's current price.
View analysts price targets for BIFF or view top-rated stocks among Wall Street analysts.

Biffa's stock was trading at GBX 358.50 at the beginning of 2022. Since then, BIFF stock has increased by 12.2% and is now trading at GBX 402.40.
View the best growth stocks for 2022 here.

Biffa plc (LON:BIFF) released its earnings results on Wednesday, June, 13th. The company reported $19.20 earnings per share for the quarter, beating the consensus estimate of $18.70 by $0.50.

Biffa declared a dividend on Tuesday, August 9th. Investors of record on Thursday, August 25th will be paid a dividend of GBX 4.69 per share on Monday, October 10th. This represents a dividend yield of 1.18%. The ex-dividend date is Thursday, August 25th. This is a positive change from the stock's previous dividend of GBX 2.20. The official announcement can be viewed at this link.
Read our dividend analysis for BIFF.

Biffa (LON:BIFF) pays an annual dividend of GBX 0.02 per share and currently has a dividend yield of 1.71%.
Read our dividend analysis for BIFF.

Based on aggregate information from My MarketBeat watchlists, some companies that other Biffa investors own include Dynavax Technologies (DVAX), Fresnillo (FRES), Aldeyra Therapeutics (ALDX), Ares Capital (ARCC), BioCryst Pharmaceuticals (BCRX), BioNTech (BNTX), Coca-Cola HBC (CCH), Centamin (CEY), Countryside Partnerships (CSP) and DDR (DDR).

Biffa trades on the London Stock Exchange (LON) under the ticker symbol "BIFF."

Shares of BIFF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of BIFF stock can currently be purchased for approximately GBX 402.40.

Biffa (LON:BIFF) has a market capitalization of £1.23 billion and generates £1.44 billion in revenue each year.

The company employs 7,357 workers across the globe.

Biffa's mailing address is Accuray House, Coronation Road, HIGH WYCOMBE, HP12 3TZ, United Kingdom. The official website for the company is www.biffa.co.uk. The company can be reached via phone at +44-1494-521221.